Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 7 days
Any time
Past hour
Past 24 hours
Past 30 days
Most recent
Best match
Pharmabiz
1d
Merck completes acquisition of investigational B-cell depletion therapy, CN201 from Curon Biopharma
Merck completes acquisition of investigational B-cell depletion therapy, CN201 from Curon Biopharma: Rahway, New Jersey Thursday, October 3, 2024, 10:00 Hrs [IST] Merck, known as ...
2d
Merck Completes Acquisition of Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
US port strike ends
Helene's wake
Accused of sexual assault
To be closed indefinitely
Sentenced to 9 yrs in prison
Ex-Memphis cops guilty
TikTok star charged
Freed from Gaza captivity
Kirk becomes Category 4
Fifth recall within a year
FDA: No longer in shortage
OH gov. declares emergency
Record heat bakes millions
'Rust' gets premiere date
To hire 250,000 workers
Golf Hall of Famer dies
California gang busted
Dream fire coach Wright
Expands online recruitment
US diagnostic errors study
Fruit fly brain mapped
5 Chinese nationals charged
CA deepfakes law blocked
Student loan plan ruling
Weekly jobless claims rise
US bans 2 Chinese firms
Disrupt Russian hackers
Israel strikes central Beirut
Mortgage rate ticks up
Surveys Helene damage
Texas AG sues TikTok
Secures $4 billion credit line
Related topics
Merck & Co.
B cell
Feedback